Literature DB >> 19030018

T-lymphocyte interaction with stromal, bone and hematopoietic cells in the bone marrow.

Francesca Di Rosa1.   

Abstract

Mature T cells in the bone marrow (BM) are in constant exchange with the blood pool. Within the BM, T-cell recognition of antigen presented by dendritic cell (DC) can occur, nevertheless it is thought that BM T cells mostly receive non-antigenic signals by either stimulatory, for example, interleukin (IL)-7, IL-15, tumor necrosis factor family members, or inhibitory molecules, for example, transforming growth factor-beta. The net balance is in favor of T-cell proliferation. Indeed, the percentage of proliferating T cells is higher in the BM than in spleen and lymph nodes, both within CD4 and CD8 T cells. High numbers of memory T cells proliferate in the BM, as they preferentially home to the BM and have an increased turnover as compared with naive T cells. I propose here that the BM plays an essential role in maintaining normal peripheral T-lymphocyte numbers and antigen-specific memory for both CD4 and CD8 T cells. I also discuss BM T-cell contribution to the homeostasis of bone metabolism as well as of hematopoiesis. It emerges that BM T cells play unexpected roles in several diseases, for example AIDS and osteoporosis. A better knowledge on BM T cells has implications for currently used clinical interventions, for example, vaccination, BM transplantation, mesenchymal stem cell-based therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19030018     DOI: 10.1038/icb.2008.84

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  31 in total

Review 1.  T cells: critical bone regulators in health and disease.

Authors:  Roberto Pacifici
Journal:  Bone       Date:  2010-05-07       Impact factor: 4.398

2.  Editorial: T cell memory, bone marrow, and aging: the good news.

Authors:  Rita B Effros
Journal:  J Leukoc Biol       Date:  2012-02       Impact factor: 4.962

3.  Interleukin-2-mediated inhibition of dendritic cell development correlates with decreased CD135 expression and increased monocyte/macrophage precursors.

Authors:  Alan D Guerrero; Matthew B Dong; Yongge Zhao; Annie Lau-Kilby; Kristin V Tarbell
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

4.  Role of Cell-Intrinsic and Environmental Age-Related Changes in Altered Maintenance of Murine T Cells in Lymphoid Organs.

Authors:  John S Davies; Heather L Thompson; Vesna Pulko; Jose Padilla Torres; Janko Nikolich-Žugich
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-07-09       Impact factor: 6.053

Review 5.  The immune system and bone.

Authors:  Roberto Pacifici
Journal:  Arch Biochem Biophys       Date:  2010-06-17       Impact factor: 4.013

6.  Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses.

Authors:  Kimberly Noonan; Lakshmi Rudraraju; Anna Ferguson; Amy Emerling; Marcela F Pasetti; Carol A Huff; Ivan Borrello
Journal:  Clin Cancer Res       Date:  2012-01-12       Impact factor: 12.531

7.  β1 integrin is critical for the maintenance of antigen-specific CD4 T cells in the bone marrow but not long-term immunological memory.

Authors:  Christopher C DeNucci; Yoji Shimizu
Journal:  J Immunol       Date:  2011-02-25       Impact factor: 5.422

8.  Interleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cells.

Authors:  Annie W Lau-Kilby; Cosima C Kretz; Susanne Pechhold; Jeffrey D Price; Stephanie Dorta; Haydee Ramos; Giorgio Trinchieri; Kristin V Tarbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

Review 9.  Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal.

Authors:  Clara S Mundry; Kirsten C Eberle; Pankaj K Singh; Michael A Hollingsworth; Kamiya Mehla
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-06-21       Impact factor: 10.680

10.  Dawn of Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma.

Authors:  Karlo Perica; Lia Palomba; Renier J Brentjens
Journal:  Adv Cell Gene Ther       Date:  2018-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.